Evidence map›Paper›PMID 41549861›Full record

ArticleInternational journal of surgery (London, England)2026

Incidence, risk factors, recovery duration, and prognostic implications of gastroparesis following radical distal gastrectomy for gastric cancer: a large retrospective cohort study.

Xue Han, Lulu Zhao, Xiaoyi Luan, Zerong Wang, Penghui Niu, Wanqing Wang, Xue Yan, Chao Wang, Gongyong Liu, Jing Zhang and 2 more

Abstract read
In one paragraph

Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xue HanNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lulu ZhaoNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xiaoyi LuanNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zerong WangNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Penghui NiuNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wanqing WangNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xue YanDepartment of Surgery, Huanxing Cancer Hospital, Beijing, China.
Chao WangDepartment of Surgery, Huanxing Cancer Hospital, Beijing, China.
Gongyong LiuDepartment of Surgery, Huanxing Cancer Hospital, Beijing, China.
Jing ZhangDepartment of Surgery, Huanxing Cancer Hospital, Beijing, China.
Dongbing ZhaoNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yingtai ChenDepartment of General Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-4342-4335

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastroparesis is a significant early complication following radical distal gastrectomy (RDG) for gastric cancer. However, the full spectrum of clinical characteristics, recovery duration, and prognostic implications of postoperative gastroparesis (PGS) has yet to be elucidated clearly.

methodsPatients who underwent RDG for gastric cancer were identified from the National Cancer Center (NCC) of China between 2010 and 2020. Propensity score matching (PSM) was used to adjust for selection biases. Logistic regression models or Cox proportional hazards models were employed to identify risk factors or prognostic factors, respectively.

resultsAmong the 4649 patients who underwent RDG, 104 cases (2.2%) developed PGS. Age ≥ 60 years [odds ratio (OR), 1.600 (1.075-2.380), P = 0.020], smoking history [OR, 2.793 (1.842-4.234), P < 0.001], long operative time [OR, 1.005 (1.001-1.008), P = 0.004], intraoperative blood transfusion [OR, 2.183 (1.371-3.477), P = 0.001], low tumor differentiation [OR, 3.019 (1.877-4.856), P < 0.001], and absence of neoadjuvant therapy [OR, 4.610 (1.443-14.724), P = 0.010] were identified as independent risk factors for PGS. The median recovery time for PGS was 19 (interquartile range (IQR): 13-30) days. Multivariate analysis revealed that a greater distance from cardia to anastomosis [OR, 1.795 (1.252-2.573), P = 0.001] and older age [OR, 1.058 (1.002-1.117), P = 0.042] were associated with prolonged recovery time of PGS. No significant differences in in-hospital mortality ( P = 0.479) and overall survival (OS) ( P = 0.503) were observed between the PGS and non-PGS groups. Furthermore, multivariate analysis indicated that patients with longer PGS recovery time had worse OS compared to patients with shorter PGS recovery time [hazard ratio (HR), 0.487 (0.245-0.967), P = 0.040] and non-PGS patients [HR, 0.506 (0.281-0.911), P = 0.023].

conclusionAge, smoking history, operative time, intraoperative blood transfusion, tumor differentiation, and neoadjuvant therapy were independent risk factors for PGS after RDG. Notably, a greater distance from cardia to anastomosis was significantly associated with prolonged recovery time of PGS. Furthermore, longer PGS recovery time independently predicted poorer OS, highlighting the significance of early intervention for PGS.

Indexed as

cohort studydistal gastrectomygastric cancergastroparesis

Identifiers

PMID41549861
PMCPMC13105651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.